| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
22,366 |
20,560 |
$1.65M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,183 |
20,074 |
$1.10M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,420 |
3,083 |
$549K |
| 80053 |
Comprehensive metabolic panel |
21,230 |
16,876 |
$379K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,100 |
4,212 |
$375K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,438 |
3,749 |
$228K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,315 |
5,975 |
$217K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,336 |
1,193 |
$180K |
| 84484 |
|
10,906 |
7,463 |
$139K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,517 |
1,422 |
$130K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,362 |
2,223 |
$126K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,112 |
1,691 |
$102K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
964 |
360 |
$98K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,159 |
1,875 |
$89K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
559 |
489 |
$81K |
| 87070 |
|
3,168 |
2,848 |
$76K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,918 |
898 |
$62K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,225 |
2,982 |
$60K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,882 |
8,616 |
$59K |
| 71045 |
Radiologic examination, chest; single view |
13,630 |
11,751 |
$42K |
| 85027 |
|
29,207 |
22,641 |
$39K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
990 |
850 |
$38K |
| G0378 |
Hospital observation service, per hour |
4,185 |
2,172 |
$38K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,034 |
1,606 |
$31K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
657 |
542 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,104 |
3,816 |
$27K |
| 81001 |
|
9,602 |
8,405 |
$26K |
| A9270 |
Non-covered item or service |
9,196 |
1,748 |
$26K |
| 81025 |
|
6,184 |
5,673 |
$23K |
| 87040 |
|
3,823 |
2,696 |
$22K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
143 |
132 |
$21K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,128 |
414 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
421 |
349 |
$18K |
| 86850 |
|
1,334 |
1,098 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,523 |
14,212 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
2,374 |
2,088 |
$16K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,353 |
11,887 |
$16K |
| 87400 |
|
3,446 |
3,259 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
530 |
494 |
$13K |
| 84702 |
|
929 |
810 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
69 |
42 |
$13K |
| 73564 |
|
843 |
743 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,421 |
3,085 |
$12K |
| 70486 |
|
87 |
83 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,932 |
2,308 |
$12K |
| 73630 |
|
905 |
792 |
$10K |
| 73610 |
|
702 |
629 |
$10K |
| 80076 |
|
3,961 |
3,596 |
$9K |
| 73120 |
|
709 |
642 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
21 |
12 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
348 |
325 |
$7K |
| 87077 |
|
1,857 |
1,525 |
$7K |
| 72131 |
|
319 |
285 |
$7K |
| 81003 |
|
2,893 |
2,608 |
$7K |
| 85610 |
|
8,974 |
7,392 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
131 |
26 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
172 |
93 |
$6K |
| 83880 |
|
2,299 |
1,932 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
594 |
514 |
$5K |
| 84703 |
|
3,270 |
3,023 |
$5K |
| 85730 |
|
6,834 |
5,733 |
$5K |
| 87205 |
|
445 |
324 |
$5K |
| 83735 |
|
9,889 |
7,734 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,834 |
5,480 |
$4K |
| 74018 |
|
270 |
243 |
$4K |
| 87186 |
|
1,465 |
1,204 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,468 |
2,150 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34 |
25 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,519 |
3,939 |
$4K |
| S0028 |
Injection, famotidine, 20 mg |
812 |
752 |
$4K |
| 93971 |
|
226 |
201 |
$4K |
| 73110 |
|
471 |
411 |
$4K |
| 73080 |
|
127 |
108 |
$4K |
| 70498 |
|
32 |
26 |
$3K |
| 73030 |
|
434 |
389 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,675 |
2,561 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,934 |
4,779 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
52 |
25 |
$3K |
| 80061 |
Lipid panel |
685 |
580 |
$3K |
| 12001 |
|
59 |
58 |
$2K |
| 72110 |
|
155 |
141 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
653 |
481 |
$2K |
| 87075 |
|
18 |
12 |
$2K |
| 87420 |
|
477 |
464 |
$2K |
| C1769 |
Guide wire |
145 |
113 |
$2K |
| 83605 |
|
2,845 |
2,292 |
$2K |
| 97597 |
|
43 |
25 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,354 |
4,331 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
287 |
181 |
$1K |
| 72128 |
|
37 |
29 |
$1K |
| 72170 |
|
165 |
120 |
$1K |
| 83690 |
|
7,193 |
6,318 |
$1K |
| 74019 |
|
199 |
184 |
$1K |
| 84100 |
|
1,564 |
1,197 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,653 |
1,472 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
818 |
544 |
$919.01 |
| 76830 |
Ultrasound, transvaginal |
130 |
119 |
$872.70 |
| 10060 |
|
14 |
14 |
$859.56 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,002 |
2,189 |
$828.19 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,079 |
941 |
$807.94 |
| 82248 |
|
1,315 |
1,079 |
$773.14 |
| 86900 |
|
1,335 |
1,100 |
$678.70 |
| 87210 |
|
72 |
69 |
$611.81 |
| J3490 |
Unclassified drugs |
43 |
29 |
$595.50 |
| 96376 |
|
1,677 |
1,033 |
$587.64 |
| 85379 |
|
1,168 |
1,080 |
$586.16 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
15 |
12 |
$540.07 |
| 86901 |
|
1,330 |
1,096 |
$507.42 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
12 |
$481.99 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
857 |
795 |
$442.96 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
127 |
105 |
$411.34 |
| 90714 |
|
484 |
435 |
$337.48 |
| 93970 |
|
27 |
24 |
$329.35 |
| 73090 |
|
35 |
32 |
$291.74 |
| 84145 |
|
120 |
103 |
$291.33 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
65 |
63 |
$278.14 |
| 76377 |
|
99 |
83 |
$258.07 |
| 82150 |
|
660 |
594 |
$216.54 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
814 |
709 |
$195.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
965 |
782 |
$154.83 |
| J2060 |
Injection, lorazepam, 2 mg |
689 |
541 |
$81.63 |
| J1815 |
Injection, insulin, per 5 units |
552 |
268 |
$78.70 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
352 |
301 |
$63.43 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
295 |
247 |
$58.02 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
65 |
63 |
$28.08 |
| 36415 |
Collection of venous blood by venipuncture |
62 |
40 |
$25.82 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
38 |
28 |
$15.37 |
| J2704 |
Injection, propofol, 10 mg |
22 |
12 |
$11.76 |
| 84439 |
|
44 |
38 |
$9.14 |
| 86140 |
|
190 |
171 |
$3.00 |
| 87147 |
|
13 |
12 |
$2.59 |
| C9113 |
Injection, pantoprazole sodium, per vial |
99 |
79 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
57 |
24 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
167 |
116 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
15 |
12 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
60 |
54 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
62 |
37 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
37 |
24 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
797 |
514 |
$0.00 |
| 85652 |
|
102 |
93 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
77 |
68 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
16 |
13 |
$0.00 |
| 73502 |
|
16 |
12 |
$0.00 |